Human Milk Oligosaccharides: Structure and Functions.

Q1 Medicine
Nestle Nutrition Institute workshop series Pub Date : 2020-01-01 Epub Date: 2020-03-11 DOI:10.1159/000505339
Lars Bode
{"title":"Human Milk Oligosaccharides: Structure and Functions.","authors":"Lars Bode","doi":"10.1159/000505339","DOIUrl":null,"url":null,"abstract":"<p><p>Oligosaccharides are a group of complex glycans that are present in the milk of most mammals. However, human milk is unique as the concentrations of human milk oligosaccharides (HMOs) are much higher than those of other mammals, and their structural composition is more complex and varies between women. These observations prompt several questions: (i) Why are humans unique when it comes to milk oligosaccharides? (ii) Which maternal genetic and environmental factors drive the interindividual variation in HMO composition? (iii) What are the short- and long-term health benefits for the infant - and potentially also the mother? The combination of genome-wide association studies, milk transcriptomics, in vitro gene editing, and in silico pathway modeling allows us to reconstruct HMO biosynthetic pathways. Using new data mining approaches and leveraging samples and metadata from large mother-infant cohorts enable us to identify associations between HMO composition and infant and maternal health outcomes. Suitable preclinical models and clinical intervention studies allow us to corroborate the established associations for causal relationships and test for in vivo efficacy in humans. Knowledge generated from these different approaches will help us establish true structure-function relationships and provide the rigorous evidence required to improve infant health and development.</p>","PeriodicalId":18986,"journal":{"name":"Nestle Nutrition Institute workshop series","volume":"94 ","pages":"115-123"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000505339","citationCount":"31","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nestle Nutrition Institute workshop series","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000505339","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/3/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 31

Abstract

Oligosaccharides are a group of complex glycans that are present in the milk of most mammals. However, human milk is unique as the concentrations of human milk oligosaccharides (HMOs) are much higher than those of other mammals, and their structural composition is more complex and varies between women. These observations prompt several questions: (i) Why are humans unique when it comes to milk oligosaccharides? (ii) Which maternal genetic and environmental factors drive the interindividual variation in HMO composition? (iii) What are the short- and long-term health benefits for the infant - and potentially also the mother? The combination of genome-wide association studies, milk transcriptomics, in vitro gene editing, and in silico pathway modeling allows us to reconstruct HMO biosynthetic pathways. Using new data mining approaches and leveraging samples and metadata from large mother-infant cohorts enable us to identify associations between HMO composition and infant and maternal health outcomes. Suitable preclinical models and clinical intervention studies allow us to corroborate the established associations for causal relationships and test for in vivo efficacy in humans. Knowledge generated from these different approaches will help us establish true structure-function relationships and provide the rigorous evidence required to improve infant health and development.

人乳低聚糖:结构与功能。
低聚糖是一组复杂的聚糖,存在于大多数哺乳动物的乳汁中。然而,母乳的独特之处在于,母乳中低聚糖(HMOs)的浓度远高于其他哺乳动物,其结构组成更为复杂,在不同女性之间也有所不同。这些观察结果引发了几个问题:(1)为什么在牛奶低聚糖方面,人类是独一无二的?(ii)哪些母体遗传和环境因素驱动HMO组成的个体间差异?(三)对婴儿和可能对母亲的短期和长期健康有什么好处?全基因组关联研究、牛奶转录组学、体外基因编辑和硅途径建模的结合使我们能够重建HMO生物合成途径。使用新的数据挖掘方法并利用来自大型母婴队列的样本和元数据,使我们能够确定HMO组成与婴儿和孕产妇健康结果之间的关联。适当的临床前模型和临床干预研究使我们能够证实已建立的因果关系和对人体体内功效的测试。从这些不同的方法中产生的知识将帮助我们建立真正的结构-功能关系,并提供改善婴儿健康和发育所需的严格证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nestle Nutrition Institute workshop series
Nestle Nutrition Institute workshop series Medicine-Pediatrics, Perinatology and Child Health
CiteScore
4.30
自引率
0.00%
发文量
22
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信